Department of Radiology and Biomedical Imaging

Total Page:16

File Type:pdf, Size:1020Kb

Department of Radiology and Biomedical Imaging DEPARTMENT OF RADIOLOGY AND BIOMEDICAL IMAGING 2019–2020 Above: Transverse (top row) and coronal (bottom row) PET/CT images obtained after administration of 89Zr-DFO-VRC01, a radiolabeled broadly neutralizing antibody against the HIV envelope protein gp120, in a HIV patient on antiretroviral therapy (ART). The left panels are CT images, the right panels are PET images and the center panels are colorized PET images overlaid on the CT image. Uptake of the labeled antibody in the spine may be related to the persistent HIV reservoir. On the cover: Erika Padilla-Morales, CNMT, Nuclear Medicine Technologist, Molecular Imaging and Therapeutics, UCSF China Basin Imaging Center (photo by Marco Sanchez, UCSF Campus Life Services) Executive Editor: Christopher Hess, MD, PhD Managing Editor: Katie Murphy Editorial Consultants: Daniel Dominguez-Moncada, Rita Gaber, Clinton Louie, Hanh Ryan Editorial Assistant: Luisa Delgado Copyediting: DEF Communications Design: Laura Myers Design © 2020 The Regents of the University of California TABLE OF CONTENTSTABLE In This Issue MESSAGE FROM THE CHAIR 2 Dr. Chris Hess reflects on the department’s recent accomplishments CLINICAL AND RESEARCH NEWS 4 Molecular Imaging of the HIV Reservoir: A First-in-Human Study 6 UCSF Launches Artificial Intelligence Center to Advance Medical Imaging 10 Peripheral Nerve Ultrasound in Clinical Practice 11 Augmenting Radiology: Using Augmented Reality Tools for Education and Clinical Care 12 The Promise and Perils of Molecular Diagnosis and Therapy 13 UCSF Radiology Faculty Support Global Health Efforts DEPARTMENT UPDATE 18 New Faculty 21 Departmental Strategic Planning 22 A New Clinical Section: Molecular Imaging and Therapeutics 24 New Appointments 25 2019 Retirements 25 In Memoriam EDUCATION 29 Radiology Training Programs 2019-2020 31 PGY-2 Residents: Class of 2023 34 Goldberg Center for Medical Student Education 35 Masters of Science in Biomedical Imaging – Learning the Fundamentals of Medical Imaging 36 A Focus on Diversity and Inclusion 37 Margulis Society 38 Alumni News 40 Honor Roll of Donors 41 Radiology Continuing Medical Education PHOTO GALLERY 42 Department Highlights RESEARCH 44 Improving Care Through Research 45 Neuro Research Group 46 Body Research Group 48 Vascular and Cardiac Research Group 49 Advanced Imaging Technologies Specialized Research Group 50 The Center for Intelligent Imaging (Ci2) 51 Chemistry, Probes and Molecular Therapy Specialized Resource Group CLINICAL SECTIONS 52 Abdominal Imaging 52 Breast Imaging 52 Cardiac and Pulmonary Imaging 53 Interventional Radiology 53 Molecular Imaging and Therapeutics 54 Musculoskeletal 54 Neuroradiology 55 Neuro Interventional 55 Pediatric Radiology 56 SFVAMC 56 Zuckerberg San Francisco General IMAGES 2019–2020 1 MESSAGE FROM THE CHAIR Dear Friends: hen I wrote this letter in late February 2020, conversion of radiograph images to an electronic COVID-19 cases were relatively few in format (PACS) occurred over 30 years ago. Our W San Francisco. Much has changed in recent field has become exceptionally skilled at delivering weeks across the U.S., and the story of COVID-19 predictions and guidance for individuals. For what is still unfolding in our city and in California. While medical questions do you seek answers: The the pandemic has consumed much of our present appropriate treatment for a patient presenting with a attention and is reshaping UCSF as I write now, this stroke? Predicted response of a cancer to surgery issue of Images reflects on our accomplishments in or chemotherapy? The extent of injury or prognosis the past year, which was outstanding for the UCSF after traumatic injury? The minimally invasive treatment Department of Radiology and Biomedical Imaging. with the best outcome? The Center for Intelligent Several recent accolades illustrate the achievements Imaging will develop and apply AI to devise powerful of our faculty and trainees. Doximity once again new ways to look inside the body and to evaluate recognized our residency as a leading training program health and disease. in the country. According to the latest data from No successful endeavor comes without challenges. the Academy for Radiology & Biomedical Imaging Chief among these: how to manage the growth of Research, for the first time our National Institutes of our clinical enterprise while maintaining focus on Health funding exceeded $56M, placing us second our academic mission. To this point, exam volume is in total funding to radiology departments nationwide. growing at a rate that is rapidly exceeding radiologist Overall, US News & World Report rated our hospitals capacity. Higher spatial resolution, multiple contrasts, among the nation’s top 10 and first in Northern volumetric acquisition with standard multiplanar California, bolstered by top-ranking clinical programs in reformatting and multi-modality techniques such as radiology. We have a lot to be proud of! CT/PET and MR/PET also continue to increase the But statistics and rankings fail to recognize the information content in each exam. The number of true excellence of our department’s people and images in a single cross-sectional examination has programs. As you will read in these pages, our grown by a factor of at least 10 for most of our studies, faculty, trainees and staff represent radiology’s elite. which greatly adds to “eye time” for our radiologists. Our department’s clinical, research and educational Some of our PET/MR examinations have over 10,000 programs define the standard of practice. Decades individual images! of energy and enthusiasm for innovation, the broad Further, the clinical expansion of UCSF Health international dissemination of our brand, and a thriving fuels the growth in imaging volumes. At our Mission and inquisitive work environment make UCSF the best Bay campus, the Precision Cancer Medicine Building place in the world to learn and practice the art and opened in the spring of 2019. Construction is almost science of Radiology. complete for the Weill Institute for Neurosciences, This year, the department launched the Center for which opens in late 2020, followed soon thereafter by a Intelligent Imaging, or CI2, to accelerate the application new psychiatry building and the UCSF Center for Vision of artificial intelligence (AI) in radiology, leveraging Neuroscience. A new outpatient building is planned at advanced computational techniques and industry Mission Bay, and UCSF Health is extending its practice collaborations to improve patient diagnoses and around the Bay Area. After upgrading our CT/PET care. (See feature article on page 6.) Through years capabilities this year at our China Basin Landing facility, of evolution, Radiology has become a central hub we will begin construction for additional MR and CT/ for information in medicine, always on the forefront PET scanners to our clinical space there. At Parnassus of digital innovation. As some of us recall, the first Heights, we completed an initial renovation to create a 2 IMAGES 2019–2020 MESSAGE FROM THE CHAIR more modern, patient-friendly face for the Department; our next Parnassus project will add PET/CT and MR equipment to meet patient needs. Even as our physical footprint in San Francisco grows, the institution is also expanding its reach outside of the city. UCSF Health opened its doors for primary and specialty care across the Bay at the Berkeley Outpatient Center, a joint venture with John Muir Health. The integration with the UCSF Benioff Children’s Hospital Oakland continues, and the health system has finalized formal strategic affiliation agreements with Marin General Hospital. We look forward to working with our colleagues, many of whom are also alumni, through these new affiliations and partnerships. While growth may be perceived as a challenge, it offers major opportunities. We are at a unique point in the history of our field, a time that requires us to re-imagine the practice of radiology. We will develop innovative ways to gather and assimilate data, to interact with and interpret images and other data, to deliver treatments precisely, as well as to communicate, deliver information, and improve our work climate. Critical to achieving these goals: training the next generation of radiologists and imaging scientists, recruiting and retaining the best minds in the field, providing the best possible clinical service to patients and investing in our research programs. As you read through the pages of Images, I hope that you enjoy these glimpses into the future of our field. To see this bright future for yourself, please feel free to visit us at any of the UCSF sites across the city, at Zuckerberg San Francisco General Hospital, or at the San Francisco Veterans Administration Medical Center. Christopher Hess, MD, PhD Alexander R. Margulis Distinguished Professor, and Chair of the Department of Radiology and Biomedical Imaging IMAGES 2019–2020 3 CLINICAL AND RESEARCH NEWS Molecular Imaging of the HIV Reservoir: A First-in-Human Study Denis Beckford Vera, PhD; Henry VanBrocklin, PhD; Robert Flavell, MD, PhD; Timothy Henrich, MD cquired immunodeficiency syndrome (AIDS), caused Broadly neutralizing antibodies (bnAbs), developed by by human immunodeficiency virus-1 (HIV-1), remains the Vaccine Research Center at the National Institutes of A a serious global health threat. According to Health, interact with the HIV envelope protein gp120 at UNAIDS global statistics at the end of 2018 (https://www. the CD4 binding site (Zhou, et al., Science 329: 811-17, unaids.org/en/resources/fact-sheet),
Recommended publications
  • Dissecting the Genetic Relationship Between Cardiovascular Risk Factors and Alzheimer's Disease
    UC San Diego UC San Diego Previously Published Works Title Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease. Permalink https://escholarship.org/uc/item/7137q6g1 Journal Acta neuropathologica, 137(2) ISSN 0001-6322 Authors Broce, Iris J Tan, Chin Hong Fan, Chun Chieh et al. Publication Date 2019-02-01 DOI 10.1007/s00401-018-1928-6 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Acta Neuropathologica https://doi.org/10.1007/s00401-018-1928-6 ORIGINAL PAPER Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer’s disease Iris J. Broce1 · Chin Hong Tan1,2 · Chun Chieh Fan3 · Iris Jansen4 · Jeanne E. Savage4 · Aree Witoelar5 · Natalie Wen6 · Christopher P. Hess1 · William P. Dillon1 · Christine M. Glastonbury1 · Maria Glymour7 · Jennifer S. Yokoyama8 · Fanny M. Elahi8 · Gil D. Rabinovici8 · Bruce L. Miller8 · Elizabeth C. Mormino9 · Reisa A. Sperling10,11 · David A. Bennett12 · Linda K. McEvoy13 · James B. Brewer13,14,15 · Howard H. Feldman14 · Bradley T. Hyman10 · Margaret Pericak‑Vance16 · Jonathan L. Haines17,18 · Lindsay A. Farrer19,20,21,22,23 · Richard Mayeux24,25,26 · Gerard D. Schellenberg27 · Kristine Yafe7,8,28 · Leo P. Sugrue1 · Anders M. Dale3,13,14 · Danielle Posthuma4 · Ole A. Andreassen5 · Celeste M. Karch6 · Rahul S. Desikan1 Received: 22 September 2018 / Revised: 28 October 2018 / Accepted: 28 October 2018 © Springer-Verlag GmbH Germany, part of Springer Nature 2018 Abstract Cardiovascular (CV)- and lifestyle-associated risk factors (RFs) are increasingly recognized as important for Alzheimer’s disease (AD) pathogenesis. Beyond the ε4 allele of apolipoprotein E (APOE), comparatively little is known about whether CV-associated genes also increase risk for AD.
    [Show full text]
  • Dissecting the Genetic Relationship Between
    VU Research Portal Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease Broce, Iris J; Tan, Chin Hong; Fan, Chun Chieh; Jansen, Iris; Savage, Jeanne E; Witoelar, Aree; Wen, Natalie; Hess, Christopher P; Dillon, William P; Glastonbury, Christine M; Glymour, Maria; Yokoyama, Jennifer S; Elahi, Fanny M; Rabinovici, Gil D; Miller, Bruce L; Mormino, Elizabeth C; Sperling, Reisa A; Bennett, David A; McEvoy, Linda K; Brewer, James B published in Acta Neuropathologica 2019 DOI (link to publisher) 10.1007/s00401-018-1928-6 document version Publisher's PDF, also known as Version of record document license Article 25fa Dutch Copyright Act Link to publication in VU Research Portal citation for published version (APA) Broce, I. J., Tan, C. H., Fan, C. C., Jansen, I., Savage, J. E., Witoelar, A., Wen, N., Hess, C. P., Dillon, W. P., Glastonbury, C. M., Glymour, M., Yokoyama, J. S., Elahi, F. M., Rabinovici, G. D., Miller, B. L., Mormino, E. C., Sperling, R. A., Bennett, D. A., McEvoy, L. K., ... Desikan, R. S. (2019). Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease. Acta Neuropathologica, 137, 209-226. https://doi.org/10.1007/s00401-018-1928-6 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
    [Show full text]
  • NIH Public Access Author Manuscript JAMA Neurol
    NIH Public Access Author Manuscript JAMA Neurol. Author manuscript; available in PMC 2014 August 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: JAMA Neurol. 2014 February ; 71(2): 180–187. doi:10.1001/jamaneurol.2013.4560. The role of clusterin in amyloid-β associated neurodegeneration Rahul S. Desikan, MD, PhD1, Wesley K. Thompson, PhD2, Dominic Holland, PhD3, Christopher P. Hess, MD, PhD4, James B. Brewer, MD, PhD1,3, Henrik Zetterberg, MD, PhD5,6, Kaj Blennow, MD, PhD5, Ole A. Andreassen, MD, PhD2,7, Linda K. McEvoy, PhD1,#, Bradley T. Hyman, MD, PhD8,#, Anders M. Dale, PhD1,2,#, and for the Alzheimer's Disease Neuroimaging Initiative* 1Department of Radiology, University of California, San Diego, La Jolla, CA, USA 2Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA 3Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA 4Neuroradiology Section, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA 5Clinical Neurochemistry Laboratory, The Sahlgrenska Academy at Göteburg University, Mölndal, 40530, Gotheburg, Sweden 6UCL Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom 7Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway 8Department of Neurology, Massachusetts General Hospital, Boston, MA, USA Abstract Importance—Converging evidence indicates that clusterin, a chaperone glycoprotein, influences Alzheimer's disease (AD) neurodegeneration. However, the precise role of clusterin in AD pathogenesis is still not well understood. Objective—To elucidate the relationship between clusterin, amyloid-β (Aβ), p-tau, and rate of brain atrophy over time among non-demented older individuals.
    [Show full text]
  • Image Processing and Analysis Methods for the Adolescent Brain Cognitive Development Study
    NeuroImage 202 (2019) 116091 Contents lists available at ScienceDirect NeuroImage journal homepage: www.elsevier.com/locate/neuroimage Image processing and analysis methods for the Adolescent Brain Cognitive Development Study Donald J. Hagler Jr. a,*, SeanN. Hatton a, M. Daniela Cornejo a, Carolina Makowski b, Damien A. Fair c, Anthony Steven Dick d, Matthew T. Sutherland d, B.J. Casey e, Deanna M. Barch f, Michael P. Harms f, Richard Watts e, James M. Bjork g, Hugh P. Garavan h, Laura Hilmer a, Christopher J. Pung a, Chelsea S. Sicat a, Joshua Kuperman a, Hauke Bartsch a, Feng Xue a, Mary M. Heitzeg i, Angela R. Laird d, Thanh T. Trinh a, Raul Gonzalez d, Susan F. Tapert a, Michael C. Riedel d, Lindsay M. Squeglia j, Luke W. Hyde i, Monica D. Rosenberg e, Eric A. Earl c, Katia D. Howlett k, Fiona C. Baker l, Mary Soules i, Jazmin Diaz a, Octavio Ruiz de Leon a, Wesley K. Thompson a, Michael C. Neale g, Megan Herting m,n, Elizabeth R. Sowell n, Ruben P. Alvarez o, Samuel W. Hawes d, Mariana Sanchez d, Jerzy Bodurka p, Florence J. Breslin p, Amanda Sheffield Morris p, Martin P. Paulus p, W. Kyle Simmons p, Jonathan R. Polimeni q,r, Andre van der Kouwe q,r, Andrew S. Nencka s, Kevin M. Gray j, Carlo Pierpaoli t, John A. Matochik u, Antonio Noronha u, Will M. Aklin k, Kevin Conway k, Meyer Glantz k, Elizabeth Hoffman k, Roger Little k, Marsha Lopez k, Vani Pariyadath k, Susan RB. Weiss k, Dana L.
    [Show full text]
  • Dissecting the Genetic Relationship Between
    VU Research Portal Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease Broce, Iris J; Tan, Chin Hong; Fan, Chun Chieh; Jansen, Iris; Savage, Jeanne E; Witoelar, Aree; Wen, Natalie; Hess, Christopher P; Dillon, William P; Glastonbury, Christine M; Glymour, Maria; Yokoyama, Jennifer S; Elahi, Fanny M; Rabinovici, Gil D; Miller, Bruce L; Mormino, Elizabeth C; Sperling, Reisa A; Bennett, David A; McEvoy, Linda K; Brewer, James B published in Acta Neuropathologica 2019 DOI (link to publisher) 10.1007/s00401-018-1928-6 document version Publisher's PDF, also known as Version of record document license Article 25fa Dutch Copyright Act Link to publication in VU Research Portal citation for published version (APA) Broce, I. J., Tan, C. H., Fan, C. C., Jansen, I., Savage, J. E., Witoelar, A., Wen, N., Hess, C. P., Dillon, W. P., Glastonbury, C. M., Glymour, M., Yokoyama, J. S., Elahi, F. M., Rabinovici, G. D., Miller, B. L., Mormino, E. C., Sperling, R. A., Bennett, D. A., McEvoy, L. K., ... Desikan, R. S. (2019). Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease. Acta Neuropathologica, 137, 209-226. https://doi.org/10.1007/s00401-018-1928-6 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
    [Show full text]
  • ADGC) Collaboration and Data Sharing Summary
    Alzheimer’s Disease Genetics Consortium (ADGC) Collaboration and Data Sharing Summary Alzheimer’s Disease Genetics Consortium (ADGC) NIA grant U01AG032984 Collaboration and Data Sharing Summary ADGC lead investigators Gerard D. Schellenberg, PI: University of Pennsylvania Lindsay Farrer: Boston University Jonathan Haines: Case Western Reserve University Richard Mayeux: Columbia University Margaret Pericak-Vance: University of Miami Li-San Wang: University of Pennsylvania The ADGC was formed to collaboratively use the collective resources of the AD research community to identify Alzheimer’s disease (AD) genes. These genes include those that cause AD, increase or decrease AD risk, and protect against AD. The ADGC includes investigators with the clinical, neuropathological, molecular and statistical expertise needed to analyze the complex phenotype of AD. The ADGC assembled genetic and phenotype data for a large number of AD cases and cognitively normal elderly controls. For non-Hispanic whites (NHW), subjects include 17,876 cases and 19,440 controls (Table 1A). For other ethnic groups (African Americans, Caribbean Hispanic, non-Caribbean Hispanics, and Asians), the subjects include 9,392 AD cases and 15,125 controls (Table 1B). Through a variety of approaches, the ADGC continues to add to this collection of cohorts. The following describes the collaborations established and the data sharing activities of the ADGC. I. ADGC collaborative network. The ADGC collaborates with 21 different cohorts in the US (Table 1A, B). The largest cohort is from the 31 NIA-funded Alzheimer’s Disease Centers (ADC’s) which have contributed 7,428 cases and 7,342 controls to ADGC studies. While the majority of subjects are non-Hispanic Caucasians (Table 1A), the ADGC also assembled and analyzed genetic and phenotype data for Hispanics, African Americans, and Asians (Table 1B).
    [Show full text]
  • Polygenic Hazard Score: an Enrichment Marker for Alzheimer's Associated Amyloid and Tau Deposition
    Acta Neuropathologica (2018) 135:85–93 https://doi.org/10.1007/s00401-017-1789-4 ORIGINAL PAPER Polygenic hazard score: an enrichment marker for Alzheimer’s associated amyloid and tau deposition Chin Hong Tan1 · Chun Chieh Fan2 · Elizabeth C. Mormino3 · Leo P. Sugrue1 · Iris J. Broce1 · Christopher P. Hess1 · William P. Dillon1 · Luke W. Bonham4 · Jennifer S. Yokoyama4 · Celeste M. Karch5 · James B. Brewer6,7,8 · Gil D. Rabinovici4 · Bruce L. Miller4 · Gerard D. Schellenberg9 · Karolina Kauppi7 · Howard A. Feldman6 · Dominic Holland6 · Linda K. McEvoy7 · Bradley T. Hyman10 · David A. Bennett11 · Ole A. Andreassen12,13 · Anders M. Dale2,6,7 · Rahul S. Desikan1,4 · For the Alzheimer’s Disease Neuroimaging Initiative Received: 20 September 2017 / Revised: 10 November 2017 / Accepted: 10 November 2017 / Published online: 24 November 2017 © Springer-Verlag GmbH Germany, part of Springer Nature 2017 Abstract There is an urgent need for identifying nondemented individuals at the highest risk of progressing to Alzheimer’s disease (AD) dementia. Here, we evaluated whether a recently validated polygenic hazard score (PHS) can be integrated with known in vivo cerebrospinal fuid (CSF) or positron emission tomography (PET) biomarkers of amyloid, and CSF tau pathology to prospectively predict cognitive and clinical decline in 347 cognitive normal (CN; baseline age range = 59.7–90.1, 98.85% white) and 599 mild cognitively impaired (MCI; baseline age range = 54.4–91.4, 98.83% white) individuals from the Alz- heimer’s Disease Neuroimaging Initiative 1, GO, and 2. We further investigated the association of PHS with post-mortem amyloid load and neurofbrillary tangles in the Religious Orders Study and Memory and Aging Project (ROSMAP) cohort (N = 485, age at death range = 71.3–108.3).
    [Show full text]
  • CXCR4 Involvement in Neurodegenerative Diseases Luke W
    Bonham? et al. Translational Psychiatry (2018) 8:73 DOI 10.1038/s41398-017-0049-7 Translational Psychiatry ARTICLE Open Access CXCR4 involvement in neurodegenerative diseases Luke W. Bonham1,CelesteM.Karch 2, Chun C. Fan 3, Chin Tan 4,EthanG.Geier1, Yunpeng Wang 5, Natalie Wen2, Iris J. Broce4,YiLi4, Matthew J. Barkovich 4, Raffaele Ferrari6,JohnHardy6, Parastoo Momeni7, Günter Höglinger 8,9, Ulrich Müller10,ChristopherP.Hess4, Leo P. Sugrue4, William P. Dillon4, Gerard D. Schellenberg11, Bruce L. Miller1, Ole A. Andreassen 5,AndersM.Dale3,12,A.JamesBarkovich4, Jennifer S. Yokoyama1 and Rahul S. Desikan, International FTD-Genomics Consortium (IFGC), International Parkinson’sDiseaseGenetics Consortium (IPDGC), International Genomics of Alzheimer’s Project (IGAP)4 Abstract Neurodegenerative diseases likely share common underlying pathobiology. Although prior work has identified susceptibility loci associated with various dementias, few, if any, studies have systematically evaluated shared genetic risk across several neurodegenerative diseases. Using genome-wide association data from large studies (total n = 82,337 cases and controls), we utilized a previously validated approach to identify genetic overlap and reveal common pathways between progressive supranuclear palsy (PSP), frontotemporal dementia (FTD), Parkinson’s disease (PD) and Alzheimer’s disease (AD). In addition to the MAPT H1 haplotype, we identified a variant near the chemokine receptor CXCR4 that was jointly associated with increased risk for PSP and PD. Using bioinformatics tools, we found strong physical interactions between CXCR4 and four microglia related genes, namely CXCL12, TLR2, RALB, and CCR5. Evaluating gene expression from post-mortem brain tissue, we found that expression of CXCR4 and microglial genes 1234567890():,; 1234567890():,; functionally related to CXCR4 was dysregulated across a number of neurodegenerative diseases.
    [Show full text]
  • CXCR4 Involvement in Neurodegenerative Diseases Celeste M
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2018 CXCR4 involvement in neurodegenerative diseases Celeste M. Karch Natalie Wen Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Bonham? et al. Translational Psychiatry (2018) 8:73 DOI 10.1038/s41398-017-0049-7 Translational Psychiatry ARTICLE Open Access CXCR4 involvement in neurodegenerative diseases Luke W. Bonham1,CelesteM.Karch 2, Chun C. Fan 3, Chin Tan 4,EthanG.Geier1, Yunpeng Wang 5, Natalie Wen2, Iris J. Broce4,YiLi4, Matthew J. Barkovich 4, Raffaele Ferrari6,JohnHardy6, Parastoo Momeni7, Günter Höglinger 8,9, Ulrich Müller10,ChristopherP.Hess4, Leo P. Sugrue4, William P. Dillon4, Gerard D. Schellenberg11, Bruce L. Miller1, Ole A. Andreassen 5,AndersM.Dale3,12,A.JamesBarkovich4, Jennifer S. Yokoyama1 and Rahul S. Desikan, International FTD-Genomics Consortium (IFGC), International Parkinson’sDiseaseGenetics Consortium (IPDGC), International Genomics of Alzheimer’s Project (IGAP)4 Abstract Neurodegenerative diseases likely share common underlying pathobiology. Although prior work has identified susceptibility loci associated with various dementias, few, if any, studies have systematically evaluated shared genetic risk across several neurodegenerative diseases. Using genome-wide association data from large studies (total n = 82,337 cases and controls), we utilized a previously validated approach to identify genetic overlap and reveal common pathways between progressive supranuclear palsy (PSP), frontotemporal dementia (FTD), Parkinson’s disease (PD) and Alzheimer’s disease (AD). In addition to the MAPT H1 haplotype, we identified a variant near the chemokine receptor CXCR4 that was jointly associated with increased risk for PSP and PD. Using bioinformatics tools, we found strong physical interactions between CXCR4 and four microglia related genes, namely CXCL12, TLR2, RALB, and CCR5.
    [Show full text]
  • Shared Genetic Risk Between Corticobasal Degeneration, Progressive Supranuclear Palsy, and Frontotemporal Dementia
    UC San Diego UC San Diego Previously Published Works Title Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. Permalink https://escholarship.org/uc/item/78j6x9mk Journal Acta neuropathologica, 133(5) ISSN 0001-6322 Authors Yokoyama, Jennifer S Karch, Celeste M Fan, Chun C et al. Publication Date 2017-05-01 DOI 10.1007/s00401-017-1693-y Peer reviewed eScholarship.org Powered by the California Digital Library University of California Acta Neuropathol (2017) 133:825–837 DOI 10.1007/s00401-017-1693-y ORIGINAL PAPER Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia Jennifer S. Yokoyama1 · Celeste M. Karch2 · Chun C. Fan3 · Luke W. Bonham1 · Naomi Kouri4 · Owen A. Ross4 · Rosa Rademakers4 · Jungsu Kim4 · Yunpeng Wang5 · Günter U. Höglinger6 · Ulrich Müller7 · Raffaele Ferrari8 · John Hardy8 · International FTD-Genomics Consortium (IFGC) · Parastoo Momeni9 · Leo P. Sugrue10 · Christopher P. Hess10 · A. James Barkovich10 · Adam L. Boxer1 · William W. Seeley1 · Gil D. Rabinovici1 · Howard J. Rosen1 · Bruce L. Miller1 · Nicholas J. Schmansky11 · Bruce Fischl11,12 · Bradley T. Hyman13 · Dennis W. Dickson4 · Gerard D. Schellenberg14 · Ole A. Andreassen6 · Anders M. Dale3,15 · Rahul S. Desikan10 Received: 14 December 2016 / Revised: 1 March 2017 / Accepted: 2 March 2017 / Published online: 7 March 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract Corticobasal degeneration (CBD), progressive and p values) from large genome-wide association studies supranuclear palsy (PSP) and a subset of frontotemporal (total n 14,286 cases and controls) and recently estab- = dementia (FTD) are neurodegenerative disorders charac- lished genetic methods, we investigated the genetic over- terized by tau inclusions in neurons and glia (tauopathies).
    [Show full text]
  • An Analysis of Genome-Wide Association Studies
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2018 Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome- wide association studies Celeste M. Karch Washington University School of Medicine in St. Louis Natalie Wen Washington University School of Medicine in St. Louis et al. Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Karch, Celeste M.; Wen, Natalie; and et al., ,"Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome- wide association studies." PLoS Medicine.15,1. e1002487. (2018). https://digitalcommons.wustl.edu/open_access_pubs/6813 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. RESEARCH ARTICLE Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies Iris Broce1*, Celeste M. Karch2, Natalie Wen2, Chun C. Fan3, Yunpeng Wang4,5, Chin Hong Tan1, Naomi Kouri6, Owen A. Ross6, GuÈ nter U. HoÈglinger7,8,9, Ulrich Muller10, John Hardy11, International FTD-Genomics Consortium¶, Parastoo Momeni12, Christopher P. Hess1, William P. Dillon1, Zachary A. Miller13, Luke W. Bonham13, Gil D. Rabinovici13, Howard J. Rosen13, Gerard D. Schellenberg14, Andre Franke15, Tom H. Karlsen16,17,18, Jan a1111111111 H. Veldink19, Raffaele Ferrari11, Jennifer S. Yokoyama13, Bruce L. Miller13, Ole a1111111111 A. Andreassen4,5, Anders M. Dale3,20,21, Rahul S. Desikan1,13*, Leo P. Sugrue1* a1111111111 a1111111111 1 Neuroradiology Section, Department of Radiology and Biomedical Imaging, University of California, San a1111111111 Francisco, San Francisco, California, United States of America, 2 Department of Psychiatry, Washington University, St.
    [Show full text]
  • Partitioning the Genetic Architecture of Amyotrophic Lateral Sclerosis
    bioRxiv preprint doi: https://doi.org/10.1101/505693; this version posted December 23, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Partitioning the genetic architecture of amyotrophic lateral sclerosis Iris J. Broce,1* Chun C. Fan,2 Nicholas T. Olney,3 Catherine Lomen-Hoerth,3 Steve Finkbeiner,3 Nazem Atassi,4 Merit E. Cudkowicz,4 Jennifer S. Yokoyama,3 Aimee Kao,3 William P. Dillon,1 Christine M. Glastonbury,1 Christopher P. Hess,1 Wouter van Rheenen,5 Jan H. Veldink,5 Ammar Al-Chalabi,6 Ole A. Andreassen,7 Anders M. Dale,2,8,9 William W. Seeley,3 Leo P. Sugrue,1 Celeste M. Karch,10 Bruce L. Miller,3* and Rahul S. Desikan1* 1Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA. 2Department of Cognitive Sciences, University of California, San Diego, La Jolla, CA, USA. 3Department of Neurology, University of California, San Francisco, CA, USA. 4Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 5Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands. 6King’s College London, Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience and Department of Neurology, King’s College Hospital, London, UK. 7Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 8Department of Radiology, University of California, San Diego, La Jolla, CA, USA 9Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA 10Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
    [Show full text]